SCHEMBL4566440

SCHEMBL4566440

C=CC=C1CCOc2ccccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ ITGB2 P05107 1/20 0.40
▸ ICAM1 P05362 1/20 0.40
▸ ITGAL P20701 1/20 0.40
▸ DYRK1A Q13627 4/20 0.37
▸ DYRK1B Q9Y463 4/20 0.37
▸ DYRK2 Q92630 3/20 0.37
▸ NPY5R Q15761 1/20 0.37
▸ LMNA P02545 2/20 0.36
▸ CRHBP P24387 2/20 0.36
▸ CRHR2 Q13324 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ HTT P42858 1/20 0.36
▸ NOTUM Q6P988 1/20 0.36
▸ PKM P14618 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ MAOB P27338 5/20 0.35
▸ CLK1 P49759 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7160349 0.78 NOTUM (0.44) MEN1KMT2AITGB2ICAM1ITGAL
SCHEMBL7160356 0.78 NOTUM (0.44) MEN1KMT2AITGB2ICAM1ITGAL
SCHEMBL6143494 0.75 ALDH1A1 (0.61) MEN1KMT2ADYRK1ADYRK1BDYRK2
SCHEMBL6142893 0.75 ALDH1A1 (0.61) MEN1KMT2ADYRK1ADYRK1BDYRK2
SCHEMBL624686 0.74 MEN1 (0.40) MEN1KMT2AITGB2ICAM1ITGAL
SCHEMBL29960518 0.74 MEN1 (0.40) MEN1KMT2AITGB2ICAM1ITGAL
SCHEMBL624687 0.74 MEN1 (0.40) MEN1KMT2AITGB2ICAM1ITGAL
SCHEMBL9772944 0.72 ESR1 (0.44) MEN1KMT2AITGB2ICAM1ITGAL
SCHEMBL1452523 0.72 ESR1 (0.44) MEN1KMT2AITGB2ICAM1ITGAL
SCHEMBL8085340 0.72 MAOB (0.62) MEN1KMT2ALMNASMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7534801-B2 Piperidinylchromen-6-ylsulfonamide compounds as 5-hydroxytryptamine-6 ligands WYETH (US) 2009-05-19 — — US disclosed
US-20050107431-A1 Piperidinylchromen-6-ylsulfonamide compounds as 5-hydroxytryptamine-6 ligands WYETH (US) 2005-05-19 — — US disclosed
WO-2005037830-A1 PIPERIDINYLCHROMEN-6-YLSULFONAMIDE COMPOUNDS AS 5-HYDROXYTRYPTAMINE-6 LIGANDS WYETH (US) 2005-04-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050107431-A1 Piperidinylchromen-6-ylsulfonamide compounds as 5-hydroxytryptamine-6 ligands HTR6, HTR5A, TPH1 MEN1 2756/4885KMT2A 2759/4885ITGB2 3965/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback